EA202192969A1 - NEW OXALILPIPERAZINES ACTIVE AGAINST HEPATITIS B VIRUS (HBV) - Google Patents

NEW OXALILPIPERAZINES ACTIVE AGAINST HEPATITIS B VIRUS (HBV)

Info

Publication number
EA202192969A1
EA202192969A1 EA202192969A EA202192969A EA202192969A1 EA 202192969 A1 EA202192969 A1 EA 202192969A1 EA 202192969 A EA202192969 A EA 202192969A EA 202192969 A EA202192969 A EA 202192969A EA 202192969 A1 EA202192969 A1 EA 202192969A1
Authority
EA
Eurasian Patent Office
Prior art keywords
hbv
virus
new
oxalilpiperazines
active against
Prior art date
Application number
EA202192969A
Other languages
Russian (ru)
Inventor
Зузанне Бонсманн
Аластэр Дональд
Андреас Урбан
Томас Голднер
Микель Анхель Перикас Брондо
Эстер Альса Барриос
Елена Детта
Джастин Раймонд
Original Assignee
Айкурис Гмбх Унд Ко. Кг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Айкурис Гмбх Унд Ко. Кг filed Critical Айкурис Гмбх Унд Ко. Кг
Priority claimed from PCT/EP2020/061920 external-priority patent/WO2020221811A1/en
Publication of EA202192969A1 publication Critical patent/EA202192969A1/en

Links

Abstract

Настоящее изобретение в целом относится к новым противовирусным средствам. Более конкретно, настоящее изобретение относится к соединениям, которые могут ингибировать белок(ки), кодируемый вирусом гепатита В (ВГВ), или нарушать функцию цикла репликации ВГВ, к композициям, содержащим такие соединения, к способам ингибирования репликации вируса ВГВ, к способам лечения или предупреждения инфекции ВГВ, а также к способам и промежуточным соединениям для получения указанных соединений.The present invention generally relates to new antiviral agents. More specifically, the present invention relates to compounds that can inhibit the protein(s) encoded by the hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions containing such compounds, methods for inhibiting HBV virus replication, methods for treating or prevention of HBV infection, as well as methods and intermediates for the preparation of said compounds.

EA202192969A 2019-05-02 2020-04-29 NEW OXALILPIPERAZINES ACTIVE AGAINST HEPATITIS B VIRUS (HBV) EA202192969A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19172402 2019-05-02
PCT/EP2020/061920 WO2020221811A1 (en) 2019-04-30 2020-04-29 Novel oxalyl piperazines active against the hepatitis b virus (hbv)

Publications (1)

Publication Number Publication Date
EA202192969A1 true EA202192969A1 (en) 2022-02-01

Family

ID=66397058

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202192969A EA202192969A1 (en) 2019-05-02 2020-04-29 NEW OXALILPIPERAZINES ACTIVE AGAINST HEPATITIS B VIRUS (HBV)

Country Status (1)

Country Link
EA (1) EA202192969A1 (en)

Similar Documents

Publication Publication Date Title
EA202091114A1 (en) NEW HIGHLY ACTIVE PYRAZOLOPIPERIDINE-SUBSTITUTED INDOL-2-CARBOXAMIDES ACTIVE AGAINST HEPATITIS B VIRUS (HBV)
EA202091113A1 (en) NEW HIGHLY ACTIVE AMINOTHIAZOL SUBSTITUTED INDOL-2-CARBOXAMIDES ACTIVE AGAINST HEPATITIS B VIRUS (HBV)
EA202191223A1 (en) NEW 6,7-DIHYDRO-4H-PYRAZOLO [1,5-a] PYRAZINE-INDOL-2-CARBOXAMIDES ACTIVE AGAINST HEPATITIS B VIRUS (HBV)
EA202191219A1 (en) NEW UREA-6,7-DIHYDRO-4H-PYRAZOLO [1,5-a] PYRAZINES, ACTIVE AGAINST HEPATITIS B VIRUS (HBV)
EA200500723A1 (en) COMPOUNDS OF BENZOFURANE, COMPOSITIONS AND METHODS OF TREATMENT AND PREVENTION OF INFECTIONS, CAUSED BY THE HEPATITIS C VIRUS, AND RELATED DISEASES
EA202191216A1 (en) NEW 6,7-DIHYDRO-4H-PYRAZOLO [1,5-a] PYRAZINE-INDOL-2-CARBOXAMIDES ACTIVE AGAINST HEPATITIS B VIRUS (HBV)
ECSP21078893A (en) NEW PHENYL AND PYRIDYL UREAS ACTIVE AGAINST HEPATITIS B VIRUS (HBV)
EA202191218A1 (en) NEW UREA-6,7-DIHYDRO-4H-PYRAZOLO [1,5-a] PYRAZINES, ACTIVE AGAINST HEPATITIS B VIRUS (HBV)
EA202191220A1 (en) NEW UREA-6,7-DIHYDRO-4H-PYRAZOLO [4,3-c] PYRIDINES ACTIVE AGAINST HEPATITIS B VIRUS (HBV)
EA202192969A1 (en) NEW OXALILPIPERAZINES ACTIVE AGAINST HEPATITIS B VIRUS (HBV)
EA202192967A1 (en) NEW INDOL-2-CARBOXAMIDES ACTIVE AGAINST HEPATITIS B VIRUS (HBV)
EA202192968A1 (en) NEW PHENYL AND PYRIDYLUREAS ACTIVE AGAINST HEPATITIS B VIRUS (HBV)
EA202192965A1 (en) NEW INDOLYSIN-2-CARBOXAMIDES ACTIVE AGAINST HEPATITIS B VIRUS (HBV)
MX2021013085A (en) Novel indole-2-carboxamides active against the hepatitis b virus (hbv).
MX2021013105A (en) Novel oxalyl piperazines active against the hepatitis b virus (hbv).
EA202191221A1 (en) NEW UREA-6,7-DIHYDRO-4H-THIAZOLO [5,4-c] PYRIDINES ACTIVE AGAINST HEPATITIS B VIRUS (HBV)
UY38681A (en) NEW INDOLIZINE-2-CARBOXAMIDES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)
EA202191109A1 (en) 5-MEMBER HETEROARYL CARBOXAMIDE COMPOUNDS FOR TREATMENT OF HEPATITIS B VIRUS
EA201892732A1 (en) ANTI-VIRUS AGENTS FOR THE TREATMENT OF HEPATITIS B
EA201892004A1 (en) ANTIVIRAL AGENTS FOR THE TREATMENT OF HEPATITIS B